Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06287736 · ClinicalTrials.gov registry record · NA

Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy

A NA study of Diabetic Peripheral Neuropathy, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06287736 is a NA study of Diabetic Peripheral Neuropathy that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 60 participants, below the 125-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06287736, a NA study of Diabetic Peripheral Neuropathy, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a prospective randomized control trial. Participants enrolled into the study will be randomized into one of three groups, two of which are treatment groups and the third is a control group. A time course of measurements before and after spinal cord stimulation (SCS) treatment (where applicable) will assess pain, DPN severity, small fiber nerve activity, and metabolic health markers.

Interventions

  • DEVICE Spinal Cord Stimulator Implantation (SCS)

Study Locations (1)

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-04-17
Est. Completion 2027-12-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT06287736

The ClinicalTrials.gov registry entry for NCT06287736 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (52% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator Implantation (SCS) is the first listed.

NCT06287736 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06287736 about?

NCT06287736 is a clinical study titled "Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy". This is a prospective randomized control trial. Participants enrolled into the study will be randomized into one of three groups, two of which are treatment groups and the third is a control group. A time course of measurements before and after spinal cord stimulation (SCS) treatment (where applicab...

What is the current status of trial NCT06287736?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-17. Estimated completion is 2027-12-31.

What conditions does trial NCT06287736 study?

This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy.

What interventions are being tested in trial NCT06287736?

The interventions under investigation include: Spinal Cord Stimulator Implantation (SCS) (DEVICE).

Who is sponsoring clinical trial NCT06287736?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06287736 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Peripheral Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.